Pharmacological Characterization of a Novel Complement C3 Inhibitor Antibody Fragment. [PDF]
Jungmichel S +8 more
europepmc +1 more source
US Retina Specialists' Preferences for Geographic Atrophy Treatment. [PDF]
Csaky K +9 more
europepmc +1 more source
GOLDEN: Efficacy and Safety of Complement Factor B Antisense, Sefaxersen, in Geographic Atrophy due to Age-Related Macular Degeneration. [PDF]
Jaffe GJ +13 more
europepmc +1 more source
Complement in brain and eye disease: shared mechanisms, convergent pathologies, and common therapeutic opportunities. [PDF]
Nimmo J +7 more
europepmc +1 more source
Consideration of patient phenotypes in geographic atrophy due to age-related macular degeneration. [PDF]
Singh RP +6 more
europepmc +1 more source
Gildeuretinol Acetate versus Placebo for Geographic Atrophy Secondary to Age-Related Macular Degeneration: The Study of ALK-001 in Geographic Atrophy Randomized Clinical Trial. [PDF]
Boyer DS +12 more
europepmc +1 more source
Association of Antibiotic Use and New-Onset ICD Coding of Geographic Atrophy. [PDF]
Smith SR +5 more
europepmc +1 more source
Visual Outcomes Following Infectious Endophthalmitis from Intravitreal Injections of Biologic Drugs: An Intelligent Research in Sight Registry Retrospective Analysis. [PDF]
Zhang R, Tunon-Robinson I, Nguyen AK.
europepmc +1 more source
New horizons in geographic atrophy treatment: enthusiasm and caution surrounding complement inhibitors. [PDF]
Lai E, Lee T, Lee C, Schechet SA.
europepmc +1 more source
Geographic Atrophy in Age-Related Macular Degeneration. [PDF]
Liakopoulos S +4 more
europepmc +1 more source

